Arrhythmia Research Technology Inc. (HRT)
-NYSE MKT 2.59 
0.05(1.97%) May 22 - Nasdaq Real Time Price
| Prev Close: | 2.59 |
|---|
| Open: | N/A |
|---|
| Bid: | 2.44 x 100 |
|---|
| Ask: | 2.60 x 3000 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 1.63 |
|---|
| Next Earnings Date: | 24-May-13 |
|---|
| Day's Range: | 2.57 - 2.60 |
|---|
| 52wk Range: | 1.89 - 3.34 |
|---|
| Volume: | 500 |
|---|
| Avg Vol (3m): | 4,771 |
|---|
| Market Cap: | 7.23M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -2.12 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ FinancialsEDGAR Online Financials(Tue, May 21)
- Arrhythmia Research Technology, Inc. Announces Delay in Finalizing First Quarter of 2013 ResultsMarketwired(Fri, May 17)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Regulation FD DisclosureEDGAR Online(Tue, May 14)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K/A, Results of Operations and Financial Condition, FinanciaEDGAR Online(Wed, May 1)
- Arrhythmia Research Technology, Inc. Receives NYSE MKT Exchange Compliance NoticeMarketwired(Tue, Apr 23)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued LisEDGAR Online(Tue, Apr 23)
- Arrhythmia Research Technology, Inc. Announces Delay in Finalizing Fourth Quarter and 2012 Year End ResultsMarketwired(Wed, Apr 17)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Thu, Apr 11)
- Arrhythmia Research Technology, Inc. Announces New President and Chief Executive OfficerMarketwired(Tue, Apr 9)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online(Wed, Apr 3)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Fri, Mar 29)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of aEDGAR Online(Fri, Mar 15)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ FinancialsEDGAR Online Financials(Wed, Nov 28)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, FinancialEDGAR Online(Tue, Nov 27)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, Nov 23)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 0.34 |
|---|
| Ex-Dividend Date: | 13-Feb-12 |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Arrhythmia Research Technology, Inc., through its subsidiaries, manufactures components, devices, and equipment primarily for the medical and defense industries.
View More